Shares of BioCryst Pharmaceuticals Inc.(BCRX.O: Quote, Profile, Research) soared 36 percent on Wednesday on news that the tiny biotechnology company has licensed an experimental compound to Roche Holding AG.
Keep an eye on it.
Subscribe to 100profit Trading Diary
Get updates delivered right to your inbox!